Cycokast 50 mg Injection

Regulated Product — Business License Required

B2B and export product information for licensed and authorized business customers. Contact our team regarding bulk supply, documentation, and applicable commercial, import, and export requirements. This page is not a storefront and no purchasing, checkout, or pricing is offered here.

Product photography not yet supplied — this space will show official packaging imagery once provided by the business.

Product Overview

Cycokast 50 mg Injection contains cisplatin, a platinum-based cytotoxic (chemotherapy) medicine. Its labelling describes it for the treatment of certain cancers, given as a single medicine or combined with radiotherapy. It is described as binding the DNA in cancer cells and preventing them from replicating, which stops the growth and division of cancer cells. It is given only by a professional doctor under supervision and must never be self-administered.

Active ingredient
Cisplatin
Strength
50 mg
Dosage form
Solution / concentrate for solution for infusion
Therapeutic class
Platinum-based alkylating agent (antineoplastic)
Regulatory status
Prescription / regulated — confirmed per enquiry and destination market
Availability
Confirmed per enquiry

Product Information

The following description reflects information associated with this product’s labelling. It has not been independently clinically verified by SDO Pharma and is provided for business and product-identification purposes only. It is not medical advice and does not replace the manufacturer’s official prescribing information.

Described Uses

  • Described for the treatment of testicular tumour, ovarian tumour, and bladder tumour
  • Described for the treatment of lung cancer and head and neck epithelial tumour
  • Described for the treatment of cervical cancer
  • Described as given as a single medicine or combined with radiotherapy
Note: SDO Pharma has not independently verified the manufacturer’s efficacy claims for this product and makes no additional medical or clinical claims beyond what is described here. We do not claim FDA, UAE, EU, or other specific regulatory approval for this product unless independently verified. This is a prescription / regulated-status product; patient dispensing is the responsibility of the licensed business customer, not SDO Pharma.

Described Dosage & Administration

  • Given only by a professional doctor under supervision
  • No individual should self-administer the injection
  • The dose is determined by the treating doctor

Described Side Effects

Commonly described side effects include:

  • Blood clots in a vein
  • Fast, irregular, or slow heartbeats
  • Decreased bone marrow function
  • Decreased white blood cells, red blood cells, and platelets (thrombocytopenia)
  • Low sodium level in the blood
  • High temperature
  • Vomiting

Any severe, persistent, or unexpected reaction requires prompt medical attention.

Precautions

  • Before starting, the doctor should be informed of any issues with the kidney, liver, or blood
  • Effective contraception should be used to avoid pregnancy
  • Stored below 25°C and not refrigerated; kept away from direct sunlight and out of reach of children

This summary is provided for informational purposes only and does not replace the manufacturer’s official product labelling or professional medical advice.

B2B, Import & Export

B2B, Import & Export Enquiries

SDO Pharma supports business enquiries for pharmaceutical and healthcare products, including bulk and export supply, subject to applicable licensing, regulatory, import, and export requirements. Requirements vary according to the destination market and the nature of the transaction.

We do not claim that this product is available for import into every country, and we do not claim FDA, UAE, EU, or other specific regulatory approval unless independently verified. Applicable documentation — including a valid Drug License, tax registration, and Importer Exporter Code (IEC) where relevant — is discussed directly with our team as part of the enquiry process. This is a regulated / prescription-status product supplied only to licensed and authorized business customers; SDO Pharma does not sell it directly to individual patients or consumers. See our Regulated Products Policy.

Product Enquiry

Request Product Information

Interested in this product for your business? Submit your enquiry and our team will contact you regarding bulk supply, documentation, and applicable requirements.

Frequently Asked Questions

Per its labelling it contains cisplatin and is used for the treatment of several cancers, including testicular, ovarian, bladder, lung, cervical, and head and neck tumours, alone or with radiotherapy. SDO Pharma has not independently verified the manufacturer’s claims and does not claim any specific regulatory approval unless independently confirmed.

Its labelling describes it as given only by a professional doctor under supervision, and never self-administered.

Licensed and authorized business customers can submit the product enquiry form above or contact our team directly. Product availability, documentation, and supply arrangements are confirmed per enquiry.

Availability depends on the destination market’s regulatory requirements and cannot be confirmed without a direct enquiry. See our B2B, Import & Export Enquiries section above.

Explore More

Related Product Categories

SDO Pharma works across several pharmaceutical and healthcare product categories for business customers.

View Products & Services